NeoStem Oncology

NeoStem Oncology LLC discovers, produces, and supplies human cell populations for research, diagnostic, clinical, and therapeutic applications. The company provides stem cell culture media, such as serum-free medium for the propagation of human embryonic stem cells (hESC); serum-free medium for human myoblast proliferation; serum-free medium formulations for propagating hESC and differentiating them into ectodermal lineages; and products for laboratory research purposes. The company also offers human motor neuron progenitor cells, human cardiac progenitor cells, and human neuronal progenitor cells for screening and predictive toxicology applications, which are derived from human embryonic stem cells. Additionally, it provides Cell Transplantation Solution, an injectable solution for cell suspensions.